- Home
- ZCMD vs RLYB Comparison
ZCMD vs RLYB Comparison
Compare ZCMD & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- RLYB
- Stock Information
- Founded
- ZCMD 2012
- RLYB 2018
- Country
- ZCMD China
- RLYB United States
- Employees
- ZCMD N/A
- RLYB N/A
- Industry
- ZCMD Other Consumer Services
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- ZCMD Real Estate
- RLYB Health Care
- Exchange
- ZCMD Nasdaq
- RLYB Nasdaq
- Market Cap
- ZCMD 30.3M
- RLYB 27.2M
- IPO Year
- ZCMD 2020
- RLYB 2021
- Fundamental
- Price
- ZCMD $1.24
- RLYB $0.61
- Analyst Decision
- ZCMD
- RLYB Buy
- Analyst Count
- ZCMD 0
- RLYB 5
- Target Price
- ZCMD N/A
- RLYB $9.75
- AVG Volume (30 Days)
- ZCMD 3.5K
- RLYB 43.4K
- Earning Date
- ZCMD 01-01-0001
- RLYB 05-08-2025
- Dividend Yield
- ZCMD N/A
- RLYB N/A
- EPS Growth
- ZCMD N/A
- RLYB N/A
- EPS
- ZCMD N/A
- RLYB N/A
- Revenue
- ZCMD $17,406,104.00
- RLYB $636,000.00
- Revenue This Year
- ZCMD N/A
- RLYB N/A
- Revenue Next Year
- ZCMD N/A
- RLYB N/A
- P/E Ratio
- ZCMD N/A
- RLYB N/A
- Revenue Growth
- ZCMD 1.01
- RLYB N/A
- 52 Week Low
- ZCMD $1.00
- RLYB $0.60
- 52 Week High
- ZCMD $2.97
- RLYB $3.46
- Technical
- Relative Strength Index (RSI)
- ZCMD 45.49
- RLYB 40.91
- Support Level
- ZCMD $1.20
- RLYB $0.63
- Resistance Level
- ZCMD $1.34
- RLYB $0.73
- Average True Range (ATR)
- ZCMD 0.07
- RLYB 0.08
- MACD
- ZCMD 0.01
- RLYB 0.00
- Stochastic Oscillator
- ZCMD 22.22
- RLYB 5.46
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.